Latest Trials

EudraCT Number: 2004-000349-40

Sponsor Protocol Number: H8O-MC-GWAO

Start Date: 2004-05-19

Sponsor Name: ELI LILLY

Full Title: Efficacy of Exenatide Compared with Insulin Glargine in Patients with Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012607		5

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001321-25

Sponsor Protocol Number: 101596

Start Date: 2004-05-19

Sponsor Name: WYETH LEDERLE

Full Title: A prospective, open label, monocenter trial to evaluate the interaction between the Platelia Aspergillus ELISA test and the administration of piperacillin/tazobactam.

Medical condition: Evaluation of interference between platelia aspergillus ELISA TEST and administration of PIPERACILLIN/TAZOBACTAM.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10004018		HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001035-32

Sponsor Protocol Number: ISG-STS 04/03

Start Date: 2004-05-13

Sponsor Name: ITALIAN SARCOMA GROUP

Full Title: NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA IDENTICAL SIBLING FOR METASTATIC SOFT TISSUE SARCOMAS

Medical condition: METASTATIC SOFT TISSUE SARCOMAS

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-001253-29

Sponsor Protocol Number: KF-B-005-04

Start Date: 2004-05-13

Sponsor Name: PharmaMar SAU

Full Title: Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, a...

Medical condition: Non Small Cell Lung Cancer Stage IIIB and IV after first Line Chemotherapy

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.0		10029514		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-001647-30

Sponsor Protocol Number: ESPHALL

Start Date: 2004-04-28

Sponsor Name: A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA

Full Title: An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL)

Medical condition: Children and adolescents aged 1-17 years at diagnosis, with Ph+ALL

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	100000004864	10000844	Acute lymphoblastic leukaemia	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-002973-22

Sponsor Protocol Number: CERL080AIT03

Start Date: 2004-04-28

Sponsor Name: AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I [...] 1. AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I 2. AZIENDA POLICLINICO UMBERTO I

Full Title: Epidemiological open-label study to evaluate the frequency of helicobacter Pylori infections prior to and after equimolar switch from therapy with MMF to enteric-coated Mycophenolic Acid (MYFORTIC-...

Medical condition: Profilaxis of rejection in stable renal transplant patients

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10046694		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-005014-36

Sponsor Protocol Number: 51/2004/U

Start Date: 2004-04-27

Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Full Title: TOLLERANZA ED EFFICACIA DELL?a-TOCOFEROLO SUCCINATO NEL TRATTAMENTO DI PAZIENTI IN ETA? PEDIATRICA AFFETTI DA EPATITE CRONICA HBsAg POSITIVA

Medical condition: Potenziamento della risposta immunitaria antivirale e riduzione del danno epatico in pazienti in eta' pediatrica affetti da epatopatia cronica HBV correlata.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10019731		PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001605-10

Sponsor Protocol Number: INT 17/04

Start Date: 2004-04-27

Sponsor Name: ISTITUTO NAZIONALE PER LA CURA TUMORI

Full Title: A Phase II, open-label study of PTK787/ZK222584 in the treatment of metastatic gastrointestinal stromal tumors GISTs resistant to imatinib mesylate

Medical condition: Metastatic gastrointestinal stromal tumors GISTs

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10017992		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-005384-28

Sponsor Protocol Number: INT 42/03

Start Date: 2004-03-24

Sponsor Name: FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI

Full Title: Randomized study of high-dose chemotherapy plus rituximab (R-HDS) vs conventional chemotherapy with rituximab (R-FC) in chronic lymphocytic leukemia at high risk.

Medical condition: Chronic lymphocytic leukemia at high risk

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10008943		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000966-10

Sponsor Protocol Number: 38/2004/U/sper

Start Date: 2004-03-23

Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Full Title: na

Medical condition: ESSENTIAL HYPERTENSION

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10047065		SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

Latest Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions